Relative Value Partners Group, LLC Pfizer Inc Transaction History

Relative Value Partners Group, LLC

  • $751 Million
  • Q2 2024

A detailed history of Relative Value Partners Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Relative Value Partners Group, LLC holds 28,589 shares of PFE stock, worth $785,053. This represents 0.11% of its overall portfolio holdings.

Number of Shares
28,589
Previous 15,917 79.61%
Holding current value
$785,053
Previous $441,000 81.18%
% of portfolio
0.11%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
BUY
$25.26 - $29.6 $320,094 - $375,091
12,672 Added 79.61%
28,589 $799,000
Q1 2024

May 13, 2024
SELL
$25.89 - $29.73 $85,695 - $98,406
-3,310 Reduced 17.22%
15,917 $441,000
Q4 2023

Feb 12, 2024
BUY
$26.13 - $33.94 $3,867 - $5,023
148 Added 0.78%
19,227 $553,000
Q3 2023

Nov 13, 2023
BUY
$32.09 - $37.51 $184,645 - $215,832
5,754 Added 43.18%
19,079 $632,000
Q2 2023

Aug 11, 2023
BUY
$36.12 - $41.79 $144 - $167
4 Added 0.03%
13,325 $488,000
Q1 2023

May 12, 2023
SELL
$39.39 - $51.28 $63,929 - $83,227
-1,623 Reduced 10.86%
13,321 $543,000
Q4 2022

Feb 13, 2023
BUY
$41.75 - $54.5 $119,196 - $155,597
2,855 Added 23.62%
14,944 $766,000
Q3 2022

Nov 10, 2022
SELL
$43.76 - $53.42 $162,174 - $197,974
-3,706 Reduced 23.46%
12,089 $529,000
Q2 2022

Aug 11, 2022
SELL
$46.53 - $55.17 $64,304 - $76,244
-1,382 Reduced 8.05%
15,795 $778,000
Q1 2022

May 13, 2022
BUY
$45.75 - $56.69 $290,100 - $359,471
6,341 Added 58.52%
17,177 $889,000
Q3 2021

Nov 12, 2021
BUY
$39.25 - $50.42 $17,662 - $22,689
450 Added 4.33%
10,836 $466,000
Q2 2021

Aug 12, 2021
SELL
$35.91 - $40.68 $32,390 - $36,693
-902 Reduced 7.99%
10,386 $407,000
Q1 2021

May 12, 2021
BUY
$33.49 - $37.77 $44,809 - $50,536
1,338 Added 13.45%
11,288 $409,000
Q4 2020

Feb 12, 2021
SELL
$33.47 - $42.56 $35,143 - $44,688
-1,050 Reduced 9.55%
9,950 $366,000
Q3 2020

Nov 12, 2020
BUY
$31.75 - $37.25 $120,650 - $141,550
3,800 Added 52.78%
11,000 $404,000
Q3 2019

Nov 14, 2019
BUY
$32.49 - $42.13 $16,245 - $21,065
500 Added 7.46%
7,200 $245,000
Q2 2019

Aug 13, 2019
SELL
$36.98 - $41.52 $33,208 - $37,284
-898 Reduced 11.82%
6,700 $290,000
Q1 2019

May 14, 2019
BUY
$37.5 - $41.2 $52,425 - $57,597
1,398 Added 22.55%
7,598 $323,000
Q2 2018

Aug 13, 2018
SELL
$32.98 - $35.16 $16,490 - $17,580
-500 Reduced 7.46%
6,200 $225,000
Q1 2018

May 11, 2018
BUY
$31.91 - $37.02 $22,337 - $25,914
700 Added 11.67%
6,700 $238,000
Q2 2017

Aug 14, 2017
BUY
N/A
6,000
6,000 $202,000

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Relative Value Partners Group, LLC Portfolio

Follow Relative Value Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relative Value Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relative Value Partners Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email